Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 12,583 | 10,635 | 8,722 |
| Operating Income | -12,583 | -10,635 | -8,722 |
| Other Income | 12 | 49 | 62 |
| Pre-tax Income | -12,571 | -10,586 | -8,660 |
| Income Tax | 1 | 11 | 3 |
| Net Income Continuous | -12,572 | -10,597 | -8,663 |
| Minority Interests | -228 | -127 | -320 |
| Net Income | $-12,344 | $-10,470 | $-8,343 |
| EPS Basic Total Ops | -2.20 | -1.87 | -1.49 |
| EPS Basic Continuous Ops | -2.24 | -1.89 | -1.55 |
| EPS Diluted Total Ops | -2.20 | -1.87 | -1.49 |
| EPS Diluted Continuous Ops | -2.24 | -1.89 | -1.55 |
| EBITDA(a) | $-12,558 | $-10,611 | $-8,701 |